ATIKSHA JHAVERI: Open Payments
NPI 1780308353 · LONG ISLAND CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,139 in 44 payments from 15 companies in 2025. Trend: 2023 $740 · 2024 $856 · 2025 $1,139
Food & beverage: $1,139
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 5 | $229 |
| Galderma Laboratories, L.P. | 13 | $216 |
| Arcutis Biotherapeutics, Inc. | 1 | $141 |
| Regeneron Healthcare Solutions, Inc. | 3 | $108 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| PFIZER INC. | 4 | $66 |
| Biofrontera Inc. | 3 | $58 |
| Amgen Inc. | 3 | $58 |
| Organon LLC | 2 | $44 |
| ABBVIE INC. | 1 | $32 |
Products named: OPZELURA, Zoryve, DUPIXENT, COSENTYX, CIBINQO, OTEZLA, RINVOQ, EBGLYSS.
Industry payments across NY — which companies pay providers there.
